Congressionally funded report details diagnostic challenges and costs of rare diseases in the US
On October 18, 2021, the Government Accountability Office (GAO) published a report entitled, Rare Diseases: Although Limited, Available Evidence Suggests Medical and Other Costs Can Be Substantial. GAO found that diagnosis of any disease can be complicated, and diagnosis of rare diseases can be particularly difficult because of a variety of factors. Those with undiagnosed, misdiagnosed, or untreated rare diseases may face various negative outcomes. For example, a person's hea
Diagnostics: Moving to the forefront of Global Healthcare
Diligentia Strategy is pleased to participate at the Southeast Life Sciences conference October 27-29 in Charleston, SC. Joff Masukawa will serve as a speaker on a panel entitled. "Diagnostics: Moving to the forefront of Global Healthcare." The discussion will focus on some of the trends, innovators, and future directions for investments that help bring about the long awaited promised of “personalized medicine.” A full description of the panel and conference details can be
